the future of glp 1 drugs GLP-1 Market Size to Hit USD 132.79 Bn by 2035 ๐ฎ Today's most important technology
Description
Habener remembers that the patients 'would get halfway through the meal and say they were full and couldn't eat anymore
Both diseases are known to reduce quality of life and lead to serious complications, such as cardiovascular events and microangiopathic alterations in eyes, kidneys, and peripheral nerves
The dose used for the treatment of obesity (2.4 mg/week) is significantly more effective in determining weight loss than that used for the treatment of T2DM (1.0 mg/week) [35]
Chronic hyperglycemia contributes to oxidative stress and fibrosis, both of which disrupt normal atrial conduction
